Asclemed USA Inc.: Duloxetine DR Capsules, 30 mg, 30 count bottles, Rx, Relabeled by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC 76420-634-30, Marketed by: Ajanta Pharma USA Inc.
Recall reason: CGMP Deviations; presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the FDA acceptable intake limit.. Recalled by Asclemed USA Inc.. Distribution: US Nationwide.. Classification (Class II — potential health risk). Affected lots/NDC/dates: Lot # 050725G-30 & 050725F-30, Exp Date: 06/30/2026. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 7,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report